Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2011

01-04-2011

Proceedings of the 11th national conference on anticoagulant therapy

Preface

Author: David A. Garcia

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2011

Login to get access

Excerpt

The 11th National Conference on Anticoagulant Therapy sponsored by the Anticoagulation Forum was held in Boston, MA on May 5–7, 2011. The AC Forum continues to enjoy a committed and enthusiastic membership with participation in this year’s meeting of over 800 attendees. The AC Forum’s conference provides a unique opportunity to network and learn among professional colleagues with expertise in the diagnosis and treatment of thrombotic disorders. The 3 day conference included an outstanding roster of international expert speakers, whose presentations are published in these proceedings. As in the past, members had an opportunity to present abstracts of original research and case reports. Over 75 abstracts were presented and are reprinted in this supplement. …
Metadata
Title
Proceedings of the 11th national conference on anticoagulant therapy
Preface
Author
David A. Garcia
Publication date
01-04-2011
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2011
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-011-0567-8

Other articles of this Issue 3/2011

Journal of Thrombosis and Thrombolysis 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine